The Department of Health (DOH) reiterated that the Food and Drug Administration (FDA) has not approved any mpox vaccine to ...

Their top candidate was DNP, which has been approved since 1996 to treat Alzheimer ... produced at scale on a much shorter time scale than a new drug," said senior author Donald Ingber, M.D., Ph.D.

The Department of Health (DOH) on Monday said a spa in Makati City will be investigated after it claimed that its therapists ...

Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according to Agriculture Secretary Francisco Tiu Laurel Jr.

PH-284 is under clinical development by VistaGen Therapeutics and currently in Phase II for Cachexia. According to GlobalData, Phase II drugs for Cachexia does not have sufficient historical data to ...

Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver ...

"Hearing loss is a significant public health issue impacting millions of Americans," explains Michelle Tarver, M.D., Ph.D., acting director of the FDA's Center for Devices and Radiological Health.

US FDA approves Roche’s Ocrevus Zunovo to treat relapsing multiple sclerosis and PPMS: Basel Tuesday, September 17, 2024, 10:00 Hrs [IST] Roche announced that the United States ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient ...

Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today ...

Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...